FDA Investigator Daniel L Zheng

Daniel L Zheng has inspections in 1 countries as of 06 Oct 2023. Daniel L Zheng has collaborated with a combinined 1754 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
17
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alan R Condon, Alice S Tsao, Amber G Wardwell, Amy C Jordan, Amy M Cramer, Andrew M Abramowitz, Andrew M Barlow, Anthony C Warchut, Bijoy Panicker, Brandy N Lepage, Carl A Perez, Cassandra L Abellard, Charisse K Green, Constance Desimone, Daryl A Dewoskin, David A Oluwo, Dorothy W Lee, Dr. Robert C Horan, MD, Dr. Yubing Tang, Edmund F Mrak, Jr, Erik W Koester, Felix Maldonado, Frederick Razzaghi, Gary J Lehr, Gary T Greco, George T Allen, Jr, Gerard D Difiore, Helen B Ricalde, Jacqueline Mdiaz Albertini, James A Liubicich, James Norman, Jawaid Hamid, Jay T Wong, Jianming Li, Jie He, Joan A Loreng, John P Mistler, John R Carlson, Jonathan G Matrisciano, Jose O Hernandez, Justine M Corson, Kalavati Suvarna, PhD, Karen Mcnabb Noon, Kenneth H Williams, Kevin A Gonzalez, Kim Lthomas Cruse, Laura L Staples, Lauren N Barber, Laurie B Frazier, Lawrence W Farina, Leanna M Slarsky, Lori M Newman, Margaret E Walsh, Margaret M Sands, Marie Bbuen Bigornia, Mark C Lookabaugh, Mary Jeanet Mcgarry, Maya M Davis, Megan A Haggerty, Meredith P Soehl, Investigator, Michael Serrano, Michelle Y Clark Stuart, Mihaly S Ligmond, Mindy M Chou, Nariman Patenaude, Nazmul Hassan, Nealie C Newberger, Nicola M Fenty Stewart, Obinna R Echeozo, Paraluman S Leonin, Parul M Patel, Paul L Bellamy, Paula M Laplant, Peter Abel, Rajiv R Srivastava, Ramon E Martinez, Richard H Penta, Robert C Steyert, Robert J Martin, Rory K Geyer, Samina S Khan, Sean R Marcsisin, Shari L Kahn, Sony Mathews, Srinivas R Chennamaneni, PhD, Stacey S Degarmo, Stephen C Smith, Stephen R Souza, Terry Bridgewater, Thomas J Arista, Thomas J Mooney, Uduak M Inokon, Uttaniti Limchumroon (Tom), Wayne E Seifert, William J Leonard, Yaodong Huang, Ying Xin Fan, PhD, Yvesna C Blaise, Yvonne Y Wu

Daniel L Zheng's Documents

Publish Date Document Type Title
July, 2022 FDA 483 Response Genzyme Corporation - Form 483R, 2022-08-08
June, 2023 FDA 483 W.S. BADGER COMPANY, INC. - Form 483, 2023-06-01
July, 2022 FDA 483 Genzyme Corporation - Form 483, 2022-07-25
February, 2022 FDA 483 Amneal Pharmaceuticals LLC - Form 483, 2022-02-10
December, 2022 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2022-12-21
February, 2023 FDA 483 Denison Pharmaceuticals, LLC - Form 483, 2023-02-09
August, 2022 FDA 483 Atlantic Management Resources, Inc - Form 483, 2022-08-10
April, 2022 FDA 483 New England Life Care, d/b/a Advanced Compounding Solutions - Form 483, 2022-04-28
October, 2021 FDA 483 Berkshire Sterile Manufacturing, Inc. - Form 483, 2021-10-15
October, 2021 EIR Berkshire Sterile Manufacturing, Inc. - EIR, 2021-10-15
November, 2021 EIR Catalent Massachusetts, LLC - EIR, 2021-11-30
October, 2022 FDA 483 Lyne Laboratories, Inc. - Form 483, 2022-10-21
July, 2022 EIR Genzyme Corporation - EIR, 2022-07-25
October, 2021 FDA 483 Response Berkshire Sterile Manufacturing, Inc. - Form 483R, 2021-10-15
June, 2021 FDA 483 Pharmasol Corporation - Form 483, 2021-06-14
September, 2022 FDA 483 South Berwick Pharmacy Seacoast Compounding, Inc. - Form 483, 2022-09-30
November, 2021 FDA 483 Catalent Massachusetts, LLC - Form 483, 2021-11-30
November, 2021 FDA 483 Response Catalent Massachusetts, LLC - Form 483R, 2021-12-18
November, 2020 FDA 483 Hopkinton Drug, Inc. - Form 483, 2020-11-10
October, 2023 FDA 483 Apothecus Pharmaceutical Corp. - Form 483, 2023-10-18
December, 2023 FDA 483 Eugia US Manufacturing LLC - Form 483, 2023-12-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more